Af­ter net­ting $200M, Syn­thego to break ground on its man­u­fac­tur­ing fa­cil­i­ty

Cal­i­for­nia-based biotech Syn­thego has been main­ly fo­cused on de­vel­op­ing CRISPR-based tools to help re­searchers in acad­e­mia and biotech, but its lat­est move now is turn­ing its at­ten­tion more to­wards man­u­fac­tur­ing.

The com­pa­ny has bro­ken ground on a 20,000-square-foot man­u­fac­tur­ing fa­cil­i­ty in the San Fran­cis­co Bay Area, ex­pand­ing its GMP ca­pac­i­ty by 30 times, Syn­thego said in an email to End­points News. The fa­cil­i­ty is al­so go­ing to man­u­fac­ture ma­te­ri­als for trans­la­tion­al and clin­i­cal re­search de­vel­op­ment for cell and gene ther­a­pies as well.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER